Home » Newsletters » BioWorld Science

BioWorld Science

July 16, 1997

View Archived Issues

Dual mechanism of action for antiatherosclerotic compound Org-13061

Parke-Davis protein tyrosine kinase inhibitor has multiple activities

New carbapenem ester prodrug claimed by Nippon Lederle

Toyama claims antibacterial agents

Neurokinin antagonists developed at Zeneca

Agents with affinity for central cannabinoid receptors reported by Sanofi

Katayama's new cephems

New PLA2 inhibitors for inflammatory conditions

Cholecalciferols for leukemia prepared at Roche

Roussel Uclaf describes antiandrogenic compounds

Peptidomimetic protein farnesyltransferase inhibitors from Merck & Co.

New oral antidiabetic agents disclosed

Merck & Co. develops potent and selective pyridinone acetamide thrombin inhibitor

Mianserin studied for treatment of sexual dysfunction

SB-242084: a potent and selective 5-HT2C receptor antagonist

A new target for antiepileptic drugs

New antipsychotic agent goes head-to-head with established therapies

Intranasal flu vaccine effective and safe in children

Genesys Pharma receives Canadian approval to commence phase I trial with antisense AIDS treatment

Pharmacokinetics of nicotine carbomer enema evaluated in UC patients and volunteers

RiboGene signs marketing agreement for intranasal metoclopramide

Fujisawa comarkets Hokuriku's Ganaton

Regranex recommended for approval by FDA advisory committee

Senetek files third PLA for INVICORP

Texas Biotechnology initiates NDA filing for Novastan

Roberts acquires Searle manufacturing site

Sequus and Sam Yang sign marketing agreement for Amphocil

Roche rights to Viracept expanded

Once-daily atorvastatin vs. pravastatin for hypercholesterolemia

Athena Neurosciences and Wyeth-Ayerst copromote Naprelan

Long-acting benzodiazepines increase risk of car crashes in the elderly

Survival rates after radical prostatectomy estimated

RPR launches room-temperature formulation of DDAVP

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...